Malignant Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pemetrexed disodium with cisplatin, with or without cediranib, in malignant pleural mesothelioma; result…
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]
Phase 2 clinical trial evaluating pemetrexed disodium and cisplatin followed by surgery with or without radiation therapy for malignant pleu…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy [Phase 2]
Phase 2 trial update for pemetrexed disodium in malignant pleural mesothelioma patients without progression after first-line chemotherapy; r…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers [Phase 3]
Phase 3 trial evaluating early palliative care added to standard care versus standard care alone in patients with incurable lung or non-colo…
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107
An update on the CALGB-30107 trial reports on biomarkers of angiogenesis and disease in patients with unresectable malignant mesothelioma. T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma [Phase 2]
Phase 2 trial evaluating first-line bortezomib plus cisplatin in malignant mesothelioma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) [NA]
Completed clinical trial evaluating quality of life and survivorship care for patients undergoing HIPEC for peritoneal cancers.
-
CLINICAL_TRIALS research · 2018-06-15Clinical Trial Update: IP3R Modulation by Cancer Genes in Mesothelioma
A KU Leuven-sponsored clinical trial investigates modulation of IP3R by cancer genes in malignant mesothelioma; the current status of the st…
-
CLINICAL_TRIALS safety_alert · 2018-04-18Clinical Trial Update: Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Oshadi D and Oshadi R for malignant mesothelioma has been suspended, with safety concerns under review.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT) [Phase 1]
This is a Phase 1 clinical trial update on radical pleurectomy/decortication with intensity-modulated radiotherapy for lung cancer and malig…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) [Phase 2]
Phase 2 pilot trial of zoledronic acid in malignant mesothelioma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma [Phase 2]
Phase 2 trial evaluating pemetrexed plus cisplatin followed by surgery and radiation for mesothelioma was terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial investigating everolimus for pleural malignant mesothelioma that is unresectable.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant Mesothelioma [Phase 1]
A Phase 1 dose-escalation study of VS-5584 in combination with VS-6063 for relapsed malignant mesothelioma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Thrombin Generation and Platelet Activation in CRS/HIPEC
Clinical trial evaluating thrombin generation and platelet activation during CRS/HIPEC has completed, involving mesothelioma and other perit…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma [Phase 2]
Phase 2 trial investigating cisplatin, pemetrexed, and bevacizumab for untreated malignant mesothelioma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma [Phase 2]
This document summarizes a Phase 2 trial evaluating the combination of gemcitabine and epirubicin for malignant mesothelioma, which has comp…
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma [Phase 2]
A Phase 2 trial of tivantinib in previously treated malignant mesothelioma was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Validation of the MiCK Assay
The MiCK Assay validation trial (NCT01770665) sponsored by Pierian Biosciences has been terminated, involving mesothelioma, small cell lung …
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Capecitabine in Treating Patients With Malignant Mesothelioma [Phase 2]
A Phase 2 clinical trial evaluating capecitabine for malignant mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma [Phase 2]
Phase 2 clinical trial of PTK787/ZK 222584 (vatalanib) for unresectable malignant mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Tomotherapy Treatment for Mesothelioma [Phase 2]
Phase 2 trial evaluating Tomotherapy radiation therapy for malignant mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma [Phase 1]
Phase 1 trial of a cancer vaccine therapy with GM-CSF in patients with acute myeloid leukemia, myelodysplastic syndromes, non-small cell lun…
-
CLINICAL_TRIALS withdrawal · 2015-12-15Clinical Trial Update: Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication [Phase 3]
A Phase 3 trial comparing Progel Sealant to standard of care for patients undergoing decortication has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma [Phase 1]
A Phase 1 trial investigating cisplatin, pemetrexed, and imatinib mesylate for malignant mesothelioma has completed.